Growth Metrics

CervoMed (CRVO) Receivables - Other (2023 - 2025)

CervoMed's Receivables - Other history spans 6 years, with the latest figure at $1.4 million for Q3 2025.

  • For Q3 2025, Receivables - Other rose 415.39% year-over-year to $1.4 million; the TTM value through Sep 2025 reached $1.4 million, up 415.39%, while the annual FY2024 figure was $2.3 million, 146.26% up from the prior year.
  • Receivables - Other for Q3 2025 was $1.4 million at CervoMed, down from $2.4 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $2.4 million in Q2 2025 and bottomed at $264148.0 in Q3 2024.
  • The 3-year median for Receivables - Other is $1.5 million (2025), against an average of $1.5 million.
  • The largest annual shift saw Receivables - Other skyrocketed 146.26% in 2024 before it surged 415.39% in 2025.
  • A 3-year view of Receivables - Other shows it stood at $915404.0 in 2023, then surged by 146.26% to $2.3 million in 2024, then plummeted by 39.61% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Receivables - Other are $1.4 million (Q3 2025), $2.4 million (Q2 2025), and $1.6 million (Q1 2025).